221 related articles for article (PubMed ID: 34251481)
1. [MRI-guided minimally invasive treatment of prostate cancer].
Tollens F; Westhoff N; von Hardenberg J; Clausen S; Ehmann M; Zöllner FG; Adlung A; Bauer DF; Schoenberg SO; Nörenberg D
Radiologe; 2021 Sep; 61(9):829-838. PubMed ID: 34251481
[TBL] [Abstract][Full Text] [Related]
2. [Machine learning and multiparametric MRI for early diagnosis of prostate cancer].
Bonekamp D; Schlemmer HP
Urologe A; 2021 May; 60(5):576-591. PubMed ID: 33710363
[TBL] [Abstract][Full Text] [Related]
3. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
[TBL] [Abstract][Full Text] [Related]
4. Minimally invasive magnetic resonance image-guided prostate interventions.
van Luijtelaar A; Fütterer JJ; Bomers JG
Br J Radiol; 2022 Mar; 95(1131):20210698. PubMed ID: 34723623
[TBL] [Abstract][Full Text] [Related]
5. Unilateral lesion detected on preoperative multiparametric magnetic resonance imaging and MRI/US fusion-guided prostate biopsy is not an appropriate indication for focal therapy in prostate cancer.
Zhou Z; Zhou Y; Yan W; Sun H; Li Q; Li H; Ji Z
Urol Oncol; 2021 Oct; 39(10):730.e17-730.e22. PubMed ID: 34175215
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging in prostate cancer detection and management: a systematic review.
Monni F; Fontanella P; Grasso A; Wiklund P; Ou YC; Randazzo M; Rocco B; Montanari E; Bianchi G
Minerva Urol Nefrol; 2017 Dec; 69(6):567-578. PubMed ID: 28488844
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of multiparametric magnetic resonance imaging in identifying clinically relevant localized prostate cancer.
Williams C; Daneshvar M; Pinto P
Curr Opin Oncol; 2021 May; 33(3):244-251. PubMed ID: 33606404
[TBL] [Abstract][Full Text] [Related]
9. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
10. Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities.
Shoji S; Hiraiwa S; Hanada I; Kim H; Nitta M; Hasegawa M; Kawamura Y; Hashida K; Tajiri T; Miyajima A
Int J Clin Oncol; 2020 Apr; 25(4):509-520. PubMed ID: 32040781
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer: state of the art imaging and focal treatment.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Clin Radiol; 2017 Aug; 72(8):665-679. PubMed ID: 28385253
[TBL] [Abstract][Full Text] [Related]
13. Targeted prostate biopsy and MR-guided therapy for prostate cancer.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Abdom Radiol (NY); 2016 May; 41(5):877-88. PubMed ID: 26907717
[TBL] [Abstract][Full Text] [Related]
14. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.
Muller BG; Fütterer JJ; Gupta RT; Katz A; Kirkham A; Kurhanewicz J; Moul JW; Pinto PA; Rastinehad AR; Robertson C; de la Rosette J; Sanchez-Salas R; Jones JS; Ukimura O; Verma S; Wijkstra H; Marberger M
BJU Int; 2014 Feb; 113(2):218-27. PubMed ID: 24215670
[TBL] [Abstract][Full Text] [Related]
15. The Use of Multiparametric Magnetic Resonance Imaging (mpMRI) in the Detection, Evaluation, and Surveillance of Clinically Significant Prostate Cancer (csPCa).
Patel P; Wang S; Siddiqui MM
Curr Urol Rep; 2019 Sep; 20(10):60. PubMed ID: 31478113
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C
BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
[TBL] [Abstract][Full Text] [Related]
18. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
[TBL] [Abstract][Full Text] [Related]
19. [Artificial intelligence and radiomics in MRI-based prostate diagnostics].
Hamm CA; Beetz NL; Savic LJ; Penzkofer T
Radiologe; 2020 Jan; 60(1):48-55. PubMed ID: 31802148
[TBL] [Abstract][Full Text] [Related]
20. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.
Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A
Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
